Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's underlying version rather than changes to study details.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, indicating an updated platform build behind the page.SummaryDifference0.0%

- Check44 days agoChange DetectedRecruitment status is updated to show no participant enrollment, and new help sections plus a revised Intervention/Treatment heading with an updated revision tag (v3.6.0) were added.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 on the page, indicating a minor update to the study record documentation.SummaryDifference0.0%

- Check65 days agoChange DetectedThe study record dates were updated, with new timestamps added (2026-05-22 and 2026-05-19) and older ones removed (2026-05-18 and 2026-04-24). These changes represent administrative updates to the trial record rather than modifications to the study content.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision 3.5.4 is added with recent date stamps (2026-05-18, 2026-04-24, 2026-04) and the note 'up to approximately 8 months'; older revision 3.5.3 and earlier dates/notes (2025-07-29, 2025-07-16, 'Minimum up to 6 months', 2025-07) were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.